2007
DOI: 10.2174/138955707782331722
|View full text |Cite
|
Sign up to set email alerts
|

Privileged Structures: A Useful Concept for the Rational Design of New Lead Drug Candidates

Abstract: Privileged structures are defined as molecular frameworks which are able of providing useful ligands for more than one type of receptor or enzyme target by judicious structural modifications. In the present work, we describe some examples and applications of the usefulness of the privileged structure concept for the structural design of new drug candidates, by discussing the eligibility of such motifs, including the identification of the N-acylhydrazone template as privileged structures.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
159
0
4

Year Published

2009
2009
2018
2018

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 284 publications
(164 citation statements)
references
References 0 publications
1
159
0
4
Order By: Relevance
“…The bioactive N-acylhydrazone (NAH) moiety has been identified in a great number of lead compounds that act on different types of molecular targets [1][2][3][4]. Because of the assemblage of amide and imine functions, NAH compounds may exist as C=N double bond stereoisomers (E/Z) (Scheme 1) and as syn/antiperiplanar conformers about the amide CO-NH bond (Scheme 1) [5].…”
Section: Introductionmentioning
confidence: 99%
“…The bioactive N-acylhydrazone (NAH) moiety has been identified in a great number of lead compounds that act on different types of molecular targets [1][2][3][4]. Because of the assemblage of amide and imine functions, NAH compounds may exist as C=N double bond stereoisomers (E/Z) (Scheme 1) and as syn/antiperiplanar conformers about the amide CO-NH bond (Scheme 1) [5].…”
Section: Introductionmentioning
confidence: 99%
“…Alternatively, as multifunctional compounds can be conceived as molecules with improved efficacy, 50 some activities described above can be conjugated in a synergic way in order to achieve a better pharmacological profile, such as the antiviral and the immunostimulating activities of some GLA-amino acid conjugates, shown in Schemes 1 through 4. Ultimately, GL and GLA may be considered for its several pharmacological activities as privileged structures, 51 and potentially useful as scaffold for the design of new pharmacologically active compounds. …”
Section: New Pharmacological Activities Reported For Gl and Glamentioning
confidence: 99%
“…The NAH subunit has been described as the pharmacophoric framework of several bioactive substances from different therapeutic classes 12,13 , indicating the privileged status of this moiety, as has been recently reviewed 14 . So, in the scope of a research program aiming to design, synthesize, and perform the pharmacological evaluation of new platelet antiaggregating lead-compound candidates, we developed new functionalized furyl 1,3-benzodioxolyl-N-acylhydrazone derivatives 9 (Figure 2), designed as isosteres of the antiplatelet thienyl-NAH derivatives 7 and 8.…”
Section: Introductionmentioning
confidence: 98%